Outlook Therapeutics Inc (FRA:41O) Transcripts
Q3 2024 Outlook Therapeutics Inc Earnings Call Transcript
Aug 14, 2024
€6.3
(-7.35%)
Earnings
Q2 2024 Outlook Therapeutics Inc Earnings Call Transcript
May 16, 2024
€6.7
(-0.74%)
Earnings
Outlook Therapeutics Inc at Guggenheim Securities Inflammation & Immunology Conference Transcript
Nov 07, 2023
Outlook Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023
Outlook Therapeutics Inc Corporate Update Call Transcript
Aug 30, 2023
Outlook Therapeutics Inc at H.C. Wainwright BioConnect Investor Conference Transcript
May 02, 2023
Outlook Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Feb 14, 2023
Outlook Therapeutics Inc at JTC Team Investor CEO Spotlight Event (Virtual) Transcript
May 11, 2022
Outlook Therapeutics Inc to Discuss Results from Its Pivotal Phase 3 NORSE TWO Call Transcript
Aug 03, 2021
Outlook Therapeutics Inc R&D Day (Virtual) Transcript
May 20, 2021
Outlook Therapeutics Inc at JTC Virtual Investor KOL Roundtable Transcript
Oct 29, 2020
Outlook Therapeutics Inc Reports Topline Results for ONS-5010 from NORSE 1 Call Transcript
Aug 20, 2020
Outlook Therapeutics Inc Virtual Investor Summit Transcript
Apr 22, 2020
Outlook Therapeutics Inc at Biotechnology Industry Organization (BIO) CEO & Investor Conference Transcript
Feb 11, 2020